Wordt geladen...
Safety, Pharmacokinetics, and Dosimetry of a Long-Acting Radiolabeled Somatostatin Analog (177)Lu-DOTA-EB-TATE in Patients with Advanced Metastatic Neuroendocrine Tumors
Radiolabeled somatostatin analog therapy has become an established treatment method for patients with well to moderately differentiated unresectable or metastatic neuroendocrine tumors (NETs). The most frequently used somatostatin analogs in clinical practice are octreotide and octreotate. However,...
Bewaard in:
| Gepubliceerd in: | J Nucl Med |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Society of Nuclear Medicine
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6225536/ https://ncbi.nlm.nih.gov/pubmed/29653971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.118.209841 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|